200 related articles for article (PubMed ID: 12438226)
1. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
Hassan KA; Ang KK; El-Naggar AK; Story MD; Lee JI; Liu D; Hong WK; Mao L
Cancer Res; 2002 Nov; 62(22):6414-7. PubMed ID: 12438226
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue.
Hassan KA; El-Naggar AK; Soria JC; Liu D; Hong WK; Mao L
Clin Cancer Res; 2001 Aug; 7(8):2458-62. PubMed ID: 11489826
[TBL] [Abstract][Full Text] [Related]
4. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
[TBL] [Abstract][Full Text] [Related]
8. Hyperfractionated accelerated radiotherapy alone and with concomitant chemotherapy to the head and neck: treated within and outside of randomized clinical trials.
Hehr T; Classen J; Schreck U; Glocker S; Bamberg M; Budach W
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1424-30. PubMed ID: 15050319
[TBL] [Abstract][Full Text] [Related]
9. Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication.
Tai SK; Lee JI; Ang KK; El-Naggar AK; Hassan KA; Liu D; Lee JJ; Ren H; Hong WK; Mao L
Clin Cancer Res; 2004 Aug; 10(16):5554-7. PubMed ID: 15328196
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
Soria JC; Jang SJ; Khuri FR; Hassan K; Liu D; Hong WK; Mao L
Cancer Res; 2000 Aug; 60(15):4000-4. PubMed ID: 10945597
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy.
Prabhu R; Hinerman RW; Indelicato DJ; Morris CG; Werning JW; Vaysberg M; Amdur RJ; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2009 Aug; 32(4):401-4. PubMed ID: 19398900
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.
Jeremic B; Milicic B; Dagovic A; Vaskovic Z; Tadic L
J Clin Oncol; 2004 Sep; 22(17):3540-8. PubMed ID: 15337803
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
15. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.
Kao J; Lavaf A; Teng MS; Huang D; Genden EM
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):362-70. PubMed ID: 18164833
[TBL] [Abstract][Full Text] [Related]
17. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
Ang KK; Berkey BA; Tu X; Zhang HZ; Katz R; Hammond EH; Fu KK; Milas L
Cancer Res; 2002 Dec; 62(24):7350-6. PubMed ID: 12499279
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma.
Krstevska V
J BUON; 2009; 14(3):361-73. PubMed ID: 19810125
[TBL] [Abstract][Full Text] [Related]
20. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]